Viking Therapeutics, Inc.
Clinical trials sponsored by Viking Therapeutics, Inc., explained in plain language.
-
New weight loss pill shows promise in 13-Week trial
Disease control CompletedThis study tested an experimental daily pill called VK2735 for weight loss in 280 adults who are obese or overweight with a weight-related health issue like high blood pressure. Participants took the pill or a placebo for 13 weeks to see how much weight they lost and if it was sa…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 14:07 UTC
-
New drug shows promise for hip fracture recovery in seniors
Symptom relief CompletedThis study tested an experimental drug called VK5211 in 108 older adults (65+) who had recently broken a hip. The goal was to see if the drug could safely help them regain muscle and improve recovery. Participants took the drug or a placebo daily for 12 weeks, and researchers mea…
Phase: PHASE2 • Sponsor: Viking Therapeutics, Inc. • Aim: Symptom relief
Last updated May 17, 2026 14:00 UTC